Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer

King Faisal Specialist Hospital & Research Center

Status: Unknown

Conditions: Breast Cancer

Treatments: Drug: Adriamycin, Taxol and Cytoxan

Study type: Interventional

Funder types: Other

Identifiers

NCT00538395

RAC #981-020

Details and patient eligibility

About

Intensive sequential chemotherapy with Adriamycin Taxol and Cytoxan in the treatment of locally advanced breast cancer

Enrollment: 100 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients with locally advanced breast cancer

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)